AKAli Fuat Karacuha

Ali Fuat Karacuha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali Fuat Karacuha has a total of 214 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparing Reintervention Factors in Acute Deep Vein Thrombosis and Post-Thrombotic Syndrome

    by Ahmet Kayan, Ali Fuat Karaçuha, Ali Batuhan Yenigün, Evren Özçınar, Çağdaş Baran, Fatma Akça, Cahit Sarıca, Mustafa Şırlak, Nur Dikmen, Ali İhSan Hasde, et al.

    Background: Acute iliofemoral deep vein thrombosis (DVT) and post-thrombotic syndrome (PTS) are characterized by significant morbidity due to impaired venous drainage. Although technical success in endovascular interventions is increasing, the need for reintervention due to complications like stent thrombosis and restenosis remains the primary obstacle to long-term clinical success.Objective: This study aims to compare clinical characteristics and intraoperative findings requiring reintervention in acute DVT and PTS patients to optimize patient-specific follow-up and management strategies.Materials and Methods: We retrospectively evaluated 400 patients (184 Acute DVT, 216 PTS) who underwent iliofemoral venous stenting. A subgroup of 111 patients (51 Acute DVT, 60 PTS) undergoing reintervention for clinical or radiological failure was analyzed. Groups were statistically compared regarding demographics, reintervention indications, and intraoperative findings.Results: The 12-month primary patency rates were 72.5% for Acute DVT and 68.3% for PTS. Among those requiring reintervention, the PTS group had significantly higher rates of recent surgery/trauma (53.3% vs. 27.5%; p=0.010) and recurrent venous ulcers (48.3% vs. 23.5%; p=0.012). Intraoperatively, in-stent restenosis (ISR) was more frequent in the PTS group (66.7% vs. 47.1%; p=0.038). In the Acute DVT group, masked anatomical issues predominated, specifically contralateral outflow obstruction (15.7% vs. 3.3%; p=0.042) and untreated additional venous lesions (47.1% vs. 23.3%; p=0.015). Secondary patency rates remained high in both groups (90.2% and 85.1%).Conclusion: Reintervention etiologies for acute DVT and PTS differ significantly. Failure in PTS is associated with chronic ISR and ulcer recurrence, while missed anatomical lesions during the index procedure are decisive in acute DVT. Extensive anatomical mapping in acute cases and aggressive restenosis monitoring in PTS are critical for long-term success.

  • Outcomes of Sclerotherapy in Patients With Facial Venous Malformations: A Retrospective Study

    by Ali Bulut, Ahmet Kayan, Ali Fuat Karaçuha, Evren Özçınar

    BACKGROUND: Facial venous malformations (VMs) are congenital low-flow vascular anomalies that may cause cosmetic disfigurement and functional impairment. Because of the anatomical complexity of the facial region, management of these lesions remains challenging, and minimally invasive approaches such as sclerotherapy have gained increasing attention. OBJECTIVE: This study evaluates the efficacy, patient satisfaction, and complications of sclerotherapy in patients with facial VMs. MATERIALS AND METHODS: A retrospective analysis was conducted on 21 patients diagnosed with facial VMs and treated with polidocanol sclerotherapy between March 2000 and January 2025. Treatment response, patient satisfaction, and complications were assessed. Statistical analyses included chi-square testing and Spearman correlation. RESULTS: Of the 21 patients, 23.8% achieved an excellent response (>90% reduction), 57.1% had a significant response (50%–90%), and 19.0% showed a mild response (p = .032). CONCLUSION: Sclerotherapy is an effective and well-tolerated treatment option for facial VMs, associated with high patient satisfaction despite frequent but manageable minor complications.

  • Dejeneratif Mitral Kapak Hastalıkları

    by Ahmet Rüçhan Akar, Mehmet Cahit Sarıcaoğlu, Ali Fuat Karaçuha, İsmet Onur Tanıyan, Emre Şen, Volkan Kozluca, İrEm Dinçer, Mustafa Bahadır İnan

    Dejeneratif mitral kapak hastalığı (DMKH), aort darlığından sonra en sık görülen edinsel kapak hastalığı olup, yaşla birlikte prevalansı artan ve primer mitral yetersizliğin en sık nedeni olan bir kapak patolojisidir. Toplum temelli çalışmalarda mitral kapak prolapsusu (MVP) prevalansı genç erişkinlerde %2–3 düzeyinde iken, 65 yaş üzerindeki bireylerde %6–10’a kadar yükselmektedir. MVP, yaprakçıkların sistolde sol atriyuma ≥2 mm yer değiştirmesi ile tanımlanır ve hastalığın en belirgin fenotipini oluşturur. Fibroelastik yetersizlik (FED), ileri yaşlarda daha sık görülen; yaprakçıklarda incelme, kısalık ve kordalarda frajilite ile karakterize, çoğunlukla tek segment tutulumu (özellikle P2) ve ani kordal rüptür sonucu akut ciddi yetmezlik ile seyreden bir formdur. Barlow hastalığı ise genç yaşlarda başlayabilen, yaprakçıklarda diffüz kalınlaşma, miksomatöz dejenerasyon, fazlalık doku ve anüler dilatasyon ile karakterize; genellikle çok segmentli tutulumu olan ve aritmi riski yüksek bir fenotiptir. Ayrıca kordal rüptür, mitral anüler kalsifikasyon (MAK), mitral anülus ayrışması (disjunction) ve GAP-BAV gibi fenotipler de klinik spektrumun çeşitliliğini artırmaktadır. Tanıda ekokardiyografi temel yöntemdir. Carpentier sınıflaması (Tip I: normal hareket, Tip II: aşırı hareket/prolapsus, Tip III: kısıtlı hareket) cerrahi planlamada halen altın standarttır. Segmental anatomi analizi (A1–A2–A3, P1–P2–P3, kommissural segmentler C1-C2) onarım stratejisinin belirlenmesinde kritik rol oynar. Fonksiyonel değerlendirmede anüler dilatasyon, yaprakçık hareketleri, koaptasyon yüksekliği, jet özellikleri ve ventrikül fonksiyonları analiz edilerek kapak onarımının başarısı öngörülür. Yüksek hacimli merkezlerde uygulanan modern kapak onarım teknikleri, düşük mortalite oranları, düşük tromboemboli/enfektif endokardit riski ve replasmana göre üstün uzun dönem sağkalım sonuçlarıyla öne çıkmaktadır. Mitral cerrahiye ek olarak, atriyal fibrilasyonu (AF) olan hastalarda eş zamanlı cerrahi ablasyon önerilmekte; sol atriyal apendiks oklüzyonu (LAAO) oral antikoagülasyona ek strateji olarak inme ve tromboemboli riskini azaltmaktadır. İleri evre olgularda sıklıkla gelişen triküspit yetersizliğinde ring veya sütür ile yapılan triküspit anüloplastisi sağ ventrikül fonksiyonunun korunması açısından önemlidir. Ulusal ölçekte, mitral kapak onarım tekniklerinin yaygın ve etkin uygulanabilmesi için eğitim programları Türk Kalp Damar Cerrahisi Derneği (TKDCD) öncülüğünde sürdürülmektedir. Minimal invaziv mitral cerrahi, medyan sternotomiye alternatif olarak sağ torakotomi veya hemitorakotomi yaklaşımlarıyla daha az travma, daha hızlı iyileşme ve kozmetik avantaj sağlar. Robotik mitral cerrahi, üç boyutlu görüntüleme ve robotik enstrümantasyon sayesinde kompleks onarımlarda üstün hassasiyet sunar. Tedavi stratejilerinin belirlenmesinde multidisipliner kalp ekibi yaklaşımı günümüzde standart hale gelmiştir. Bu ekip, her hastanın klinik özelliklerini, anatomisini, cerrahi riskini ve yaşam beklentisini değerlendirerek bireyselleştirilmiş kararlar vermekte; böylece onarımın başarısı ve uzun dönem prognoz iyileştirilmektedir. Transkateter yaklaşımlar, yüksek riskli hasta grubunda cerrahiye alternatif oluşturmaktadır. Gelecek perspektifinde yapay zekâ tabanlı görüntüleme analizleri, biyomekanik modelleme, yeni nesil transkateter sistemler, 4D akım manyetik rezonans görüntüleme ve mitral yaprakçık biyolojisi üzerine translasyonel araştırmalar, bireyselleştirilmiş tedavi stratejilerinin gelişimine katkı sağlayacaktır.

  • Open Access

    Kalp ve Damar Cerrahisi (Cilt 1-2)

    by Ayşen Yaprak Kapkın, Hakan Hançer, Günseli Çubukçuoğlu Deniz, Cüneyt Konuralp, Serpil Nalbant, Mehmet Çakıcı, Deniz Süha Küçükaksu, Tümer Ulus, Onur Benli, Hafize Yalınız, et al.

  • Total Yapay Kalp

    by Mehmet Cahit Sarıcaoğlu, Serenay Ersoy, Emre Aslancı, Ali Fuat Karaçuha, Fatma Akça, Onur Büyükçakır, Ali İhSan Hasde, Ahmet Rüçhan Akar

    Total yapay kalp (TAH) tedavisi, son yıllarda önemli ilerlemeler göstermiş olup, kısa süreli destek sağlayan büyük hacimli cihazlardan, uzun dönem destinasyon tedavi seçeneği olabilecek daha kompleks sistemlere doğru evrilmiştir. Gelecek çalışmaları, mevcut sınırlamaların — boyut, dayanıklılık, enfeksiyon riski ve yaşam kalitesi — aşılmasına, ayrıca pediatrik ve kompleks komorbiditeli hasta gruplarında kullanımın genişletilmesine odaklanmaktadır. Yeni mühendislik tasarımları cihaz boyutunu ve ağırlığını azaltmayı hedeflemekte, bu sayede çocuklar ve adölesanlar dâhil daha küçük vücut yapısına sahip erişkin hastalarda implantasyonu mümkün kılmaktadır. Gelişmiş biyomalzemeler ve biyouyumlu yüzey kaplamaları tromboembolik komplikasyonları, hemolizi ve enfeksiyonu azaltmayı amaçlamakta, biyoprotez tabanlı materyallerin kullanımı ise cihazın uzun dönem dayanıklılığını ve fizyolojik entegrasyonunu artırabilecek potansiyele sahiptir.Mevcut sistemlerin en önemli zorluklarından biri perkütan driveline enfeksiyonlarıdır. Bu sorunu azaltmak amacıyla transkütan enerji transfer sistemleri (TETS) geliştirilmektedir. Bu teknoloji, tam implant edilebilir cihazlara geçişte büyük bir adım olup enfeksiyon riskini azaltmakta ve mobiliteyi artırmaktadır. Ayrıca yeni nesil TAH’lar, sensör destekli akıllı kontrol üniteleri ile gerçek zamanlı hemodinamik adaptasyon sağlayarak doğal biventriküler fizyolojiyi daha etkin şekilde taklit edebilecektir. Yapay zekâ entegrasyonu, cihaz yönetiminde prediktif bakım, kişiselleştirilmiş pompa optimizasyonu ve olası cihaz arızası ya da hemodinamik bozulmaların erken tespitine olanak sağlayacaktır. Telemonitorizasyon sistemleri sayesinde sürekli ayaktan hasta takibi mümkün olacak, güvenlik artarken hastane yatışları ve sağlık maliyetleri azalacaktır.TAH geliştirmede en kritik ihtiyaçlardan biri pediatrik hastalara yönelik cihazların yaygınlaştırılmasıdır. Küçük boyutlu ve büyüme potansiyeline uygun cihazların yanı sıra, psikososyal destek, eğitim ve erişkine geçiş sürecinin yönetimi bu hasta grubunda uzun dönem sonuçların iyileştirilmesinde temel rol oynayacaktır. Gelecekte TAH, kalp-böbrek kombinasyonları gibi çoklu organ destek stratejileriyle de bütünleşebilir. Ayrıca pulmoner hipertansiyon ve sağ ventrikül afterload yönetimini optimize edebilecek adaptif modüllerin entegrasyonu da gündemdedir. Yeni nesil biyoprotez TAH ve rotary pompa tabanlı sistemler (örneğin BiVACOR) erken klinik çalışmalarda cesaret verici sonuçlar ortaya koymaktadır. INTERMACS, EUROMACS ve uluslararası TAH kayıtlarının genişlemesi, hasta seçimini optimize etmek, cihaz tasarımını geliştirmek ve düzenleyici onay süreçlerini hızlandırmak açısından kritik veriler sağlayacaktır. TAH tedavisinin geleceği, mühendislik inovasyonlarının kişiselleştirilmiş tıp ve multidisipliner bakım ile bütünleşmesine dayanmaktadır. Miniatürizasyon, enfeksiyonsuz enerji transferi, yapay zekâ destekli izlem ve pediatrik hasta grubuna genişleme, TAH’ın köprü tedavisinden uzun dönem destinasyon tedavisine dönüşmesini mümkün kılacaktır. Teknolojinin klinik deneyimle buluşmasıyla, gelecek nesil TAH platformlarının yalnızca sağkalımı uzatmakla kalmayıp, yaşam kalitesini de belirgin olarak artırması beklenmektedir.

  • Open Access

    Early outcomes of TEVAR: Spinal cord ischemia and reintervention rates in a single-center study

    by Mehmet Cahit Saricaoglu, Fatma Akca, Evren Ozcinar, Ali Ihsan Hasde, Salih Anil Boga, Ali Fuat Karacuha, Onur Buyukcakir, Cagdas Baran, Levent Yazicioglu, Sadik Eryilmaz

    Aim: Thoracic endovascular aortic repair (TEVAR) is currently the preferred treatment for different pathologies of the thoracic aorta because of its technical advantages over open surgery. This single-center study analyzes early outcomes of TEVAR with a special focus on spinal cord ischemia (SCI) and reintervention rates and their relationship to patient and procedural variables. Material and Methods: Data were retrospectively collected from patients who underwent TEVAR between February 2012 and August 2023. Patients were classified by pathology type: thoracic aortic aneurysms (n=97, 66.4%), type B aortic dissections (n=28,19.2%), traumatic aortic injuries (n=12, 8.2%), and other pathologies (n=9, 6.2%). Primary outcomes included SCI and reintervention rates at one year post-procedure; secondary outcomes included stroke, upper extremity ischemia, and 30-day mortality. The statistical analysis used univariate and multivariate logistic regression models as well as Kaplan-Meier survival analyses with subgroup comparisons between elective and urgent cases.Results: A total of 146 patients were analyzed; 79.45% were male with an average age of 63.23±12.50 years. Of this population, 121 patients (82.9%) had elective procedures and 25 patients (17.2%) had urgent/emergent procedures; postoperative spinal cord ischemia developed in 11 patients (7.5%). The stroke rate was 13.7% (n=20).The 30-day mortality rate was significantly higher in patients undergoing urgent TEVAR compared to those undergoing elective procedures (32.0% vs. 13.2%, p=0.02). TEVAR-related reintervention was required within a year for 38 patients (26%).There are no independent predictors for spinal cord ischemia; however, the multivariate analysis shows that early reintervention has a strong association with diabetes mellitus (OR 3.2, 95% CI 1.3–7.8, p=0.01), history of smoking (OR 2.1, 95% CI 1.0–4.4, p=0.05), and lesions in distal zones (OR 2.4, 95% CI 1.1–5.2, p=0.03). Urgent cases showed a trend toward higher reintervention rates compared to elective procedures (40.0% vs. 23.1%, p=0.08). Conclusion: This study demonstrates that the risk of reintervention is increased in cases with a history of diabetes mellitus, smoking, and aortic pathologies located in the distal thoracic zone. Urgent procedures carry higher morbidity and mortality risks but should be confirmed by larger randomized multicenter studies.

  • Predictors of Mortality Correlated with the SOFA Score in Pediatric VA-ECMO Patients

    by Nur Dikmen, Zeynep Eyıleten, Oğuzhan Durmaz, Evren Özçınar, Burcu Arıcı, Ahmet Kayan, Ali Fuat Karaçuha, Merve Havan, Fatma Akça, Tayfun Uçar, et al.

    Background: The objective of this study was to analyze mortality predictors in pediatric VA-ECMO patients, correlating these predictors with the pediatric sequential organ failure assessment score (pSOFA). Aim: To enhance prognostic accuracy and support individualized clinical decision-making by evaluating the correlations between mortality predictors and pediatric sequential organ failure assessment (pSOFA) scores in pediatric VA-ECMO patients. Methods: We conducted a retrospective analysis of 80 consecutive pediatric VA-ECMO cases treated at our center between April 2018 and October 2021. Data collection included patient demographics, clinical features, pSOFA scores, and estimated mortality risks. Survival impacts and morbidity factors were also assessed. The overall decannulation and hospital discharge rates were recorded, with a particular focus on patients with congenital cardiac diseases and those experiencing postcardiotomy low cardiac output, who showed the highest survival rates. Results: Our analysis revealed that certain variables significantly influenced survival outcomes in pediatric VA-ECMO patients. These variables included age, weight, genetic disorders, inotropic support, inhaled nitric oxide (NO) usage, hemodiafiltration, duration of hospital stay, active cardiopulmonary resuscitation during cannulation, and various biochemical markers. Notably, the mean pSOFA scores were significantly lower in survivors compared to non-survivors (9.22 ± 1.43 vs. 13.06 ± 2.69, respectively). Overall decannulation and hospital discharge rates were 60% and 48.75%, respectively, with the highest rates observed in patients with congenital cardiac diseases and postcardiotomy low cardiac output (84.6% and 76.9%, respectively). Furthermore, several mortality predictors were identified, which correlated strongly with pSOFA scores. These predictors included the need for inotropic support, elevated levels of lactate and creatinine, a low protein/albumin ratio, and a low pH prior to cannulation. These findings underscore the critical importance of assessing the severity of organ failure and the overall clinical status when determining mortality risk in pediatric VA-ECMO patients. Conclusion: This study offers valuable insights into the association between pSOFA scores and mortality predictors in pediatric ECMO cases. The significant correlation between higher pSOFA scores and increased mortality highlights the necessity for comprehensive risk assessment and vigilant monitoring of clinical status to optimize patient outcomes. Our findings support the integration of pSOFA scores into routine clinical practice for more effective prognostication and individualized patient management in pediatric VA-ECMO.

  • Open Access

    Early Outcomes of TEVAR: Spinal Cord Ischemia and Reintervention Rates in a Single-Center Study

    by Mehmet Cahit Sarıcaoğlu, Fatma Akça, Evren Özçınar, Ali İhsan Hasde, Salih Anil Boğa, Ali Fuat Karaçuha, Onur Büyükçakır, Çağdaş Baran, Levent Yazıcıoğlu, Sadik Eryilmaz

    Objective: Thoracic endovascular aortic repair (TEVAR) has become the preferred treatment for various thoracic aortic pathologies due to its technical advantages over open surgery. This single-center study aims to analyze early outcomes of TEVAR, specifically focusing on spinal cord ischemia (SCI) and reintervention rates, while examining their relationships with patient and procedural variables. Methods: Data from patients who underwent TEVAR between February 2012 and August 2023 were retrospectively collected. Patients were categorized by pathology type: thoracic aortic aneurysms (n=97, 66.4%), type B aortic dissections (n=28,19.2%), traumatic aortic injuries (n=12, 8.2%), and other pathologies (n=9, 6.2%).Primary outcomes were spinal cord ischemia and 1-year reinterventions rates. Secondary outcomes included stroke, upper extremity ischemia, and 30-day mortality. Statistical analysis included univariate and multivariate logistic regression, Kaplan-Meier survival analysis, and subgroup comparisons between elective and urgent cases. Results: In the dataset of 146 patients, 116 (79.45%) were male, with an average age of 63.23 ± 12.50. Elective procedures were performed in 121 patients (82.9%) versus 25 urgent cases (17.2%). Among the complications, postoperative stroke was observed in 20 patients (13.7%), and upper extremity ischemia, likely due to occlusion of the subclavian artery, was observed in 10 patients (6.84%). Spinal cord ischemia was observed in 11 patients (7.5%), while TEVAR-related reintervention was required in 38 patients (26%). No significant relationship was found between SCI and the variables (p-value > 0.05); however, reintervention was required in 38 patients (26.0%) and was significantly associated with diabetes mellitus (OR 3.2, 95% CI 1.3-7.8, p=0.01), smoking history (OR 2.1, 95% CI 1.0-4.4, p=0.05), and distal zone lesions (OR 2.4,95% CI 1.1-5.2, p=0.03). Overall 30-day mortality was 17.1%. Urgent cases had higher 30-day mortality (32.0% vs. 13.2%, p=0.02) and reintervention rates (40.0% vs. 23.1%, p=0.08). Conclusions: This study demonstrates that the risk of reintervention is increased in cases with a history of diabetes mellitus, smoking, and aortic pathologies located in the distal thoracic zone. Urgent procedures carry higher morbidity and mortality risks. However, the current findings need to be supported by larger randomized multicenter studies.

  • Open Access

    Total Endovascular Aortic Arch Repair Using In Situ Needle Triple Fenestration and Selective Cerebral Perfusion: Single-Center Results

    by Evren Ozcinar, Fatma Akca, Mehmet Cahit Saricaoglu, Ali Ihsan Hasde, Nur Dikmen, Onur Buyukcakir, Aysegul Guven, Oguzhan Durmaz, Salih Anil Boga, Ali Fuat Karacuha, et al.

    Background: Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair (TEVAR) to include arch lesions. In situ needle fenestration (ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and Methods: A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024. The median age of the patients was 51,33 years (±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 min (range: 126–302). Two patients experienced a minor hematoma at the access site. Mortality was observed in one patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia. No procedure-related endoleak was observed during the intervention; however, eight patients required reintervention in the descending aorta. Conclusions: ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.


  • Open Access

    Total Endovascular Aortic Arch Repair Using In Situ Needle Triple Fenestration and Selective Cerebral Perfusion: Single-Center Results

    by Evren Ozcinar, Fatma Akça, Mehmet Cahit Saricaoglu, Ali Ihsan Hasde, Nur Dikmen, Onur Buyukcakir, Aysegul Güven, Oğuzhan Durmaz, Salih Anıl Boğa, Ali Fuat Karacuha, et al.

    Background:Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair(TEVAR) to include arch lesions.In situ needle fenestration(ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and methods:A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024.The median age of the patients was 51,33 years(±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 minutes (range: 126–302).Two patient experienced a minor hematoma at the access site. Mortality was observed in 1 patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia.No procedure-related endoleak was observed during the intervention; however, 8 patients required reintervention in the descending aorta. Conclusion:ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.